Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
“It’s not technology that’s holding us back. It’s business practice,” said Andy Slavitt, acting administrator of the Centers for Medicare & Medicaid Services, speaking at the Bipartisan Policy Center’s program on interoperability.
“Everywhere I go, I feel a sense of urgency” about interoperability, said Karen DeSalvo, MD, MSc, MPH, national coordinator for health IT, speaking at the Bipartisan Policy Center’s program on interoperability.
A new interoperability framework includes legal terms, policy requirements, technical specifications and governance processes to operationalize data sharing for health information exchange (HIE) networks, vendors, payers and others in the healthcare industry to help them improve their connectivity.
Use of telemedicine has expanded significantly during 2015 but enterprise telemedicine solution provider REACH Health offers up five telemedicine technology trends to consider in the new year.
The American Hospital Association's (AHA) new white paper outlines how the use of health IT can improve quality across the care continuum.
Line-of-business executives continue to bypass the CIO and IT department when making technology investments, according to the third annual Global CIO Survey from Logicalis U.S.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.